|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_ocn833132838 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130328s2013 nyu o 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d OCLCF
|d OCLCQ
|d AGLDB
|d ICA
|d D6H
|d OCLCQ
|d VTS
|d STF
|d AU@
|d M8D
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 902942605
|a 957135871
|
| 020 |
|
|
|a 9781622574995
|q (electronic bk.)
|
| 020 |
|
|
|a 1622574990
|q (electronic bk.)
|
| 020 |
|
|
|z 9781622574858
|
| 020 |
|
|
|z 1622574850
|
| 029 |
1 |
|
|a DEBBG
|b BV041049773
|
| 029 |
1 |
|
|a DEBBG
|b BV043961404
|
| 029 |
1 |
|
|a DEBSZ
|b 481300023
|
| 029 |
1 |
|
|a NZ1
|b 15029922
|
| 035 |
|
|
|a (OCoLC)833132838
|z (OCoLC)902942605
|z (OCoLC)957135871
|
| 050 |
|
4 |
|a RC182.S4
|
| 072 |
|
7 |
|a HEA
|x 039040
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022090
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.94
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Septic shock :
|b symptoms, management & risk factors /
|c edited by Melvin C. Johnston, Jerome E. Knight.
|
| 260 |
|
|
|a Hauppauge, N.Y. :
|b Nova Science ;
|a Lancaster :
|b Gazelle [distributor],
|c 2013.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Emergency and intensive care medicine
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a SEPTIC SHOCK: SYMPTOMS, MANAGEMENT AND RISK FACTORS; SEPTIC SHOCK: SYMPTOMS, MANAGEMENT AND RISK FACTORS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Pathophysiology of Cardiovascular Failure in Septic Shock; Abstract; Introduction; 1. Molecular Mechanisms in the Pathophysiology of Septic Shock; 1.1. Changes of Myocyte ion Transport by Inflammatory Mediators; Calcium Channels; Potassium Channels; 1.3. Changes in Cytoskeletal Proteins; 1.3. Mitochondrial Dysfunction in Septic Shock.
|
| 505 |
8 |
|
|a 1.4. The Role of Endotoxins and Bacterial Virulence Factors in Septic ShockEndotoxin; Effects of other Bacterial Toxins; 2. Microcirculation in Septic Shock; 3. Myocardial Dysfunction in Septic Shock; 3.1. The role of Cytokines in Myocardial Dysfunction; 3.2. Myocardial Cell Death; 3.2.1. The Role of Poly(Adenosine 5'-diphosphate-ribose); Polymerase Activation; 3.2.2. The Role of Nitric Oxide; 4. Pathophysiology of Inotrope Refractory Cardiovascular Failure; Conclusion; References; Chapter 2: Sepsis and Septic Shock: Risk Factors, Symptoms and Management; Abstract; Introduction; Risk Factors.
|
| 505 |
8 |
|
|a DefinitionsPathogenesis; Symptoms; Management; Early Management; Ongoing Management; Recommendations; References; Chapter 3: Septic Shock: Clinical Diagnosis and Risk Factors; Abstract; Abbreviations; 1. Introduction; 1.1. Basic Concepts; 1.2. Epidemiological Impact of Sepsis and Septic Shock; 2. Clinical Approach to the Septic Patient; 2.1. Suspected Sepsis in the ER; 2.2. Patients at Risk of Septic Shock; 2.3. Confirming the Diagnosis; 2.3.1. Laboratory Analyses and Work-Up; 2.3.2. Imaging Studies; 2.3.3. New Diagnostic Tools and Future Research; 2.3.3.1. Inflammatory Biomarkers.
|
| 505 |
8 |
|
|a 2.3.3.2. Oxidative Stress BiomarkersConclusion; References; Chapter 4: Diagnosis and Management of Life-Threatening Infections and Septic Shock During Idiopathic Drug-Induced Agranulocytosis; Abstract; Introduction; Criteria for the Definition of Idiopathic Drug-Induced Agranulocytosis; Epidemiology of Agranulocytosis; Incriminated Drugs in Idiopathic Agranulocytosis; Clinical Manifestations of Drug-Induced Neutropenia and Agranulocytosis; Differential Diagnosis of Acute Neutropenia; Prognosis and Mortality Rate of Drug Induced Agranulocytosis, Frailty Patients.
|
| 505 |
8 |
|
|a Management of Drug-Induced Severe Neutropenia or AgranulocytosisPrevention; General Measures; Indications of Antimicrobial Agents; Indications of Hematopoietic Growth Factors; Conclusion; References; Chapter 5: Sepsis: A Disease of the Microcirculation; Abstract; Introduction; Microcirculation; The Shunting Theory of Sepsis; Monitoring the Microcirculation; Nailfold videocapillaroscopy; Laser Doppler; Orthogonal Polarization Spectral; and Sidestream Dark Field Imaging; Near-Infrared Spectroscopy; The Microcirculation in Sepsis; Sepsis and Outcome; Vasopressors and Inotropes; Norepinephrine.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Septic shock.
|
| 650 |
|
2 |
|a Shock, Septic
|
| 650 |
|
6 |
|a Choc infectieux.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Contagious.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Infectious Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a Septic shock.
|2 fast
|0 (OCoLC)fst01112819
|
| 700 |
1 |
|
|a Johnston, Melvin C.
|
| 700 |
1 |
|
|a Knight, Jerome E.
|
| 776 |
0 |
8 |
|i Print version:
|t Septic shock.
|d Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2013
|z 9781622574858
|w (OCoLC)811732542
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541984
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 541984
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 9571294
|
| 994 |
|
|
|a 92
|b IZTAP
|
